Repeated High-dose Inhaled Corticosteroids for Asthma

Withdrawn before enrolling · Phase 2 · Has a placebo group

Conditions studied: Asthma

In brief

The purpose of this study is to to compare the effects of high-dose Inhaled Corticosteroids (ICS) vs. placebo in adults with chronic stable asthma.

Key facts

Study ID

NCT00695604

Run by

University of Chicago

People needed

0

Starts

2008-05-01

Expected to finish

2011-09-01

Last updated by the study team

2018-05-08

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Physician diagnosis of asthma.
• Age ≥18 years and ≤50 years
• Evidence of airflow obstruction as measured by spirometry and flow-volume loop per American Thoracic Society guidelines.
• Treatment for asthma with:
• daily inhaled corticosteroids and long-acting beta2-agonists, AND
• as-needed use of a short-acting beta2-agonist

You may not qualify if…

• History of >10 pack-year tobacco use
• Other pulmonary or cardiac diagnosis that is actively being treated
• History of adverse events or allergy to fluticasone
• Systemic corticosteroid therapy within 7 days of study visit
• Inability to obtain written informed consent

Where it is running

• The University of Chicago — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.